Pascal LEURAUD

I’ve created, developed and managed XenTech during 16 years.
XenTech is a French company, pionneer in preclinical expertise in oncology.
I’ve developed a company based on a worldwide recognized PDX platform with a high quality standard.
I’ve managed a dual business model having a preclinical CRO activity and a RD activity.
The CRO actvity mainly aimes at offerinfg anti-tumor efficacy tests of candidate drugs.
THe RD activity mainly aimed at discovering and validating candidate biomarkers for the development of companion diagnostic tests.